Twenty five years after identification of the HIV virus, the AIDS epidemic continues with an estimated 33 million individuals currently infected worldwide and 2.5 million new infections each year. Research to prevent and treat HIV infection has grown increasing sophisticated and the analytic challenges have become correspondingly complex. In this application we outline plans for the development of statistical methods that will be directly applicable to current problems in the field of HIV/AIDS research. In particular, we propose to develop methods for the analysis of data from stepped wedge randomized trials, trials to prevent mother to child transmission of HIV, discordant partner studies, and trials or studies which utilize two-phase or other complex sampling designs. Since HIV infection is typically asymptomatic and the time of infection is bounded by two test dates, we continue work on methods for interval censored data and focus on issues related to competing risks and correlated interval censored data. Finally, as the search for an effective HIV vaccine presents ever greater challenges, we propose to develop novel statistical methods for analyzing data from studies of T-cell based vaccines as well as HIV antigen-antibody interactions.

Public Health Relevance

This research will develop statistical methods for use in studies of HIV infection.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Research Project (R01)
Project #
Application #
Study Section
AIDS Clinical Studies and Epidemiology Study Section (ACE)
Program Officer
Gezmu, Misrak
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Biostatistics & Other Math Sci
Schools of Public Health
United States
Zip Code
Fleming, Thomas R; Ellenberg, Susan S; DeMets, David L (2018) Data Monitoring Committees: Current issues. Clin Trials 15:321-328
Chung, Yunro; Ivanova, Anastasia; Hudgens, Michael G et al. (2018) Partial likelihood estimation of isotonic proportional hazards models. Biometrika 105:133-148
Wakefield, Jon; Fuglstad, Geir-Arne; Riebler, Andrea et al. (2018) Estimating under-five mortality in space and time in a developing world context. Stat Methods Med Res :962280218767988
Kohler, Pamela K; Marumo, Eva; Jed, Suzanne L et al. (2017) A national evaluation using standardised patient actors to assess STI services in public sector clinical sentinel surveillance facilities in South Africa. Sex Transm Infect 93:247-252
Lyons, Vivian H; Li, Lingyu; Hughes, James P et al. (2017) Proposed variations of the stepped-wedge design can be used to accommodate multiple interventions. J Clin Epidemiol 86:160-167
Fu, Rong; Gilbert, Peter B (2017) Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling. Lifetime Data Anal 23:136-159
Greene, Evan; Wellner, Jon A (2017) Exponential bounds for the hypergeometric distribution. Bernoulli (Andover) 23:1911-1950
Trumble, Ilana M; Allmon, Andrew G; Archin, Nancie M et al. (2017) SLDAssay: A software package and web tool for analyzing limiting dilution assays. J Immunol Methods 450:10-16
Crouch, Luis Alexander; Zheng, Cheng; Chen, Ying Qing (2017) Estimating a Treatment Effect in Residual Time Quantiles under the Additive Hazards Model. Stat Biosci 9:298-315
Scott, JoAnna M; deCamp, Allan; Juraska, Michal et al. (2017) Finite-sample corrected generalized estimating equation of population average treatment effects in stepped wedge cluster randomized trials. Stat Methods Med Res 26:583-597

Showing the most recent 10 out of 129 publications